EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Venous Thromboembolism in the Inflammatory Rheumatic Diseases

Durga Prasanna Misra, Sakir Ahmed, Mohit Goyal, Aman Sharma, Vikas Agarwal

Rheumatic Disease Clinics of North America · 2023-02 · 49 (1) · 97-127

DOI: 10.1016/j.rdc.2022.08.001 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Rheumatic Disease Clinics of North America, 2023-02. Verfasst von Durga Prasanna Misra und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Immunology and Rheumatology, C block, Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGIMS), Rae Bareli Road, Luc…. Hauptthemen laut MEDLINE: Venous Thromboembolism, Antiphospholipid Syndrome, Rheumatic Diseases. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 109 Literaturangaben. Gefördert von: Indian Council of Medical Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Venous thromboembolism (VTE), which includes deep venous thrombosis and pulmonary embolism, is a cardiovascular event whose risk is increased in most inflammatory rheumatic diseases (IRDs). Mechanisms that increase VTE risk include antiphospholipid antibodies (APLs), particularly anticardiolipin antibodies, anti-beta2glycoprotein I antibodies and lupus anticoagulant present together, and inflammation-mediated endothelial injury. Patients with IRDs should receive long-term anticoagulation drugs when the risk of VTE recurrence is high. In the light of recent warnings from regulatory agencies regarding heightened VTE risk with Janus kinase inhibitors, these drugs should be initiated only after a careful assessment of VTE risk in those with IRDs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Venous ThromboembolismAntiphospholipid SyndromeRheumatic DiseasesHumansAntibodies, AntiphospholipidInflammation

Stichwörter der Autor:innen

Antiphospholipid antibody syndromeCardiovascular diseasesDeep venous thrombosisPulmonary embolismRheumatoid arthritisSystemic lupus erythematosusVasculitisVenous thromboembolism

Substanzen

Antibodies, Antiphospholipid

Autor:innen und Institutionen

  • Department of Clinical Immunology and Rheumatology, C block, Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGIMS), Rae Bareli Road, Lucknow 226014, India. Electronic address: durgapmisra@gmail.com.
  • Department of Clinical Immunology and Rheumatology, Kalinga Institute of Medical Sciences (KIMS), Bhubaneswar 751024, India. Electronic address: https://twitter.com/sakir_rheum.
  • Department of Rheumatology and Clinical Immunology, CARE Pain and Arthritis Centre, Udaipur 313002, Rajasthan, India. Electronic address: https://twitter.com/drmohitgoyal.
  • Department of Internal Medicine, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh 160012, India. Electronic address: https://twitter.com/Amansharmapgi.
  • Department of Clinical Immunology and Rheumatology, C block, Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGIMS), Rae Bareli Road, Lucknow 226014, India. Electronic address: https://twitter.com/vikasagrIM…

Förderung

  • Indian Council of Medical Research

Zitieren

APA

Misra, D. P., Ahmed, S., Goyal, M., Sharma, A., & Agarwal, V. (2023). Venous Thromboembolism in the Inflammatory Rheumatic Diseases. Rheumatic Disease Clinics of North America, 49(1), 97-127. https://doi.org/10.1016/j.rdc.2022.08.001

Vancouver

Misra DP, Ahmed S, Goyal M, Sharma A, Agarwal V. Venous Thromboembolism in the Inflammatory Rheumatic Diseases. Rheumatic Disease Clinics of North America. 2023;49(1):97-127. doi:10.1016/j.rdc.2022.08.001

BibTeX
@article{Misra2023,
  author = {Misra, Durga Prasanna and Ahmed, Sakir and Goyal, Mohit and Sharma, Aman and Agarwal, Vikas},
  title = {Venous Thromboembolism in the Inflammatory Rheumatic Diseases},
  journal = {Rheumatic Disease Clinics of North America},
  year = {2023},
  volume = {49},
  number = {1},
  pages = {97--127},
  doi = {10.1016/j.rdc.2022.08.001}
}
Kostenlos starten →